First antibody-drug conjugate for multiple myeloma patients with limited treatment options

View source ↗

Summary

The EMA announces the first antibody-drug conjugate approved for multiple myeloma patients with limited treatment options, offering a new targeted therapy optio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• unexplained antibody-drug conjugate (unknown)